Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today that they had exclusively licensed technology for error correction in next generation...
Read More »BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single cell analysis with the ability to detect rare molecules responsible for biological diversity that are often missed with ...
Read More »